Skip to main content

MoneyWorks4Me

Marksans Pharma informs about press release

17 Nov 2025 Evaluate
Marksans Pharma has informed that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA: 1. Mefenamic Acid 250 mg Film-Coated Tablets, 2. Mefenamic Acid 500 mg Film-Coated Tablets.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..